IHC analysis showed that the expression levels of ALPK2 in tumor tissues were much higher than those in normal tissues, thus indicating that ALPK2 may be involved in the development and progression of bladder cancer (Fig. 1A and Table 1). The gene discussed is ALPK2; the disease is urinary bladder carcinoma.